13F-HR filed by Boxer Capital, LLC
Boxer Capital, LLC filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-14, with 65 holding rows worth $2,274,579,000.
- Accession
- 0000950123-20-009123
- Filer
- CIK 1465837
- Filed
- 2020-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2020
A holdings report, 65 entries on the cover page, a total value of $2,274,579,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,274,579,000 with VALUE read as thousands by filing date, 13F file number 028-17339. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| IMMUNOMEDICS INC | 452907108 | COM | 6,606,000 | $234,117,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 1,765,560 | $201,574,000 | thousands by filing date | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 925,000 | $174,270,000 | thousands by filing date | |
| ODONATE THERAPEUTICS INC | 676079106 | COM | 3,363,377 | $142,405,000 | thousands by filing date | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 2,959,264 | $93,424,000 | thousands by filing date | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 2,075,905 | $87,188,000 | thousands by filing date | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 2,014,858 | $84,946,000 | thousands by filing date | |
| SEATTLE GENETICS INC | 812578102 | COM | 400,000 | $67,968,000 | thousands by filing date | |
| PASSAGE BIO INC | 702712100 | COM | 1,928,315 | $52,701,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 2,084,883 | $51,580,000 | thousands by filing date | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 975,000 | $50,027,000 | thousands by filing date | |
| ALLAKOS INC | 01671P100 | COM | 675,000 | $48,506,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 7,000,000 | $48,440,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 1,094,000 | $45,489,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 170,926 | $38,498,000 | thousands by filing date | |
| ATRECA INC | 04965G109 | COM | 1,733,583 | $36,891,000 | thousands by filing date | |
| PRINCIPIA BIOPHARMA INC | 74257L108 | COM | 607,000 | $36,293,000 | thousands by filing date | |
| COMPUGEN LTD | M25722105 | ORD | 2,383,673 | $35,803,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 2,325,000 | $35,061,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 765,400 | $34,489,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 2,287,782 | $33,905,000 | thousands by filing date | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 2,562,358 | $33,311,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 4,075,000 | $32,967,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 6,205,882 | $31,774,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 1,121,327 | $31,689,000 | thousands by filing date | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 2,202,812 | $31,302,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 7,034,598 | $30,882,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 250,000 | $30,835,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 1,466,051 | $30,684,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 1,300,000 | $29,042,000 | thousands by filing date | |
| MARINUS PHARMACEUTICALS INC | 56854Q101 | COM | 9,600,000 | $24,384,000 | thousands by filing date | |
| DIREXION DAILY S&P BIOTECH BEAR 3X SHARES | 25460E539 | ETF | 7,000,000 | $24,290,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 1,775,000 | $18,265,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 370,000 | $17,934,000 | thousands by filing date | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 1,566,361 | $17,434,000 | thousands by filing date | |
| NEOLEUKIN THERAPEUTICS INC | 64049K104 | COM | 1,009,255 | $16,754,000 | thousands by filing date | |
| PREVAIL THERAPEUTICS INC | 74140Y101 | COM | 1,123,105 | $16,734,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 250,000 | $15,783,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 4,000,000 | $15,720,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 844,789 | $13,770,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 300,000 | $13,425,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 1,000,000 | $13,000,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 705,882 | $12,911,000 | thousands by filing date | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 4,029,649 | $12,331,000 | thousands by filing date | |
| MEI PHARMA INC | 55279B202 | COM NEW | 2,913,091 | $12,031,000 | thousands by filing date | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 416,495 | $10,379,000 | thousands by filing date | |
| KODIAK SCIENCES INC | 50015M109 | COM | 181,138 | $9,803,000 | thousands by filing date | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 3,284,072 | $9,327,000 | thousands by filing date | |
| MATINAS BIOPHARMA HLDGS INC | 576810105 | COM | 11,478,634 | $8,873,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 600,000 | $7,524,000 | thousands by filing date | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 290,577 | $7,404,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 2,000,000 | $6,980,000 | thousands by filing date | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 317,000 | $6,169,000 | thousands by filing date | |
| ARTARA THERAPEUTICS INC | 04300J107 | COM | 209,227 | $6,135,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 126,000 | $6,037,000 | thousands by filing date | |
| ZYMEWORKS INC | 98985W102 | COM | 165,000 | $5,952,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 200,000 | $5,490,000 | thousands by filing date | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 550,000 | $5,088,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 1,531,872 | $4,488,000 | thousands by filing date | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 1,102,194 | $4,166,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 890,700 | $3,794,000 | thousands by filing date | |
| LIFESCI ACQUISITION CORP | 53228P208 | UNIT 03/31/2025 | 300,000 | $2,988,000 | thousands by filing date | |
| BELLEROPHON THERAPEUTICS INC | 078771300 | COM NEW | 98,809 | $1,240,000 | thousands by filing date | |
| CELLECTAR BIOSCIENCES INC | 15117F500 | COM PAR | 920,000 | $1,178,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 27,300 | $737,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-20-009123 | this filing | 2020-08-14 | acceptance time not in the bulk data set |